6533b7d2fe1ef96bd125e922
RESEARCH PRODUCT
Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure
Giulia RizzutoFabio Salvatore MacalusoEmanuele OrlandoMario CottoneSara RennaA. OrlandoValeria Criscuolisubject
Hepatologybiologybusiness.industryImmunoglobulin Fab FragmentsGastroenterologyInflammatory Bowel DiseasesToxicology03 medical and health sciences0302 clinical medicineAntibodies monoclonal030220 oncology & carcinogenesisMonoclonalbiology.proteinCancer researchMedicine030211 gastroenterology & hepatologyPharmacology (medical)Tumor necrosis factor alphaAnti-tumour necrosis factor alpha agentAntibodybusinessyear | journal | country | edition | language |
---|---|---|---|---|
2016-04-04 | Alimentary Pharmacology & Therapeutics |